BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15078089)

  • 41. Contact pair dynamics during folding of two small proteins: chicken villin head piece and the Alzheimer protein beta-amyloid.
    Mukherjee A; Bagchi B
    J Chem Phys; 2004 Jan; 120(3):1602-12. PubMed ID: 15268287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural differences between allelic variants of the ovine prion protein revealed by molecular dynamics simulations.
    Bujdoso R; Burke DF; Thackray AM
    Proteins; 2005 Dec; 61(4):840-9. PubMed ID: 16252284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
    Sauvé S; Tremblay L; Lavigne P
    J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prion protein: Structural features and related toxic peptides.
    Ronga L; Tizzano B; Palladino P; Ragone R; Urso E; Maffia M; Ruvo M; Benedetti E; Rossi F
    Chem Biol Drug Des; 2006 Sep; 68(3):139-47. PubMed ID: 17062011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-hairpin conformation of fibrillogenic peptides: structure and alpha-beta transition mechanism revealed by molecular dynamics simulations.
    Daidone I; Simona F; Roccatano D; Broglia RA; Tiana G; Colombo G; Di Nola A
    Proteins; 2004 Oct; 57(1):198-204. PubMed ID: 15326604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein.
    Lee SW; Mou Y; Lin SY; Chou FC; Tseng WH; Chen CH; Lu CY; Yu SS; Chan JC
    J Mol Biol; 2008 May; 378(5):1142-54. PubMed ID: 18423487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The toxicity of prion protein fragment PrP(106-126) is not mediated by membrane permeabilization as shown by a M112W substitution.
    Henriques ST; Pattenden LK; Aguilar MI; Castanho MA
    Biochemistry; 2009 May; 48(19):4198-208. PubMed ID: 19301918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toward structural dynamics: protein motions viewed by chemical shift modulations and direct detection of C'N multiple-quantum relaxation.
    Mori M; Kateb F; Bodenhausen G; Piccioli M; Abergel D
    J Am Chem Soc; 2010 Mar; 132(10):3594-600. PubMed ID: 20166666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species.
    Vieira TC; Reynaldo DP; Gomes MP; Almeida MS; Cordeiro Y; Silva JL
    J Am Chem Soc; 2011 Jan; 133(2):334-44. PubMed ID: 21142149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NMR structure of the bank vole prion protein at 20 degrees C contains a structured loop of residues 165-171.
    Christen B; Pérez DR; Hornemann S; Wüthrich K
    J Mol Biol; 2008 Nov; 383(2):306-12. PubMed ID: 18773909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Both host prion protein 131-188 subregion and prion strain characteristics regulate glycoform of PrP Sc.
    Yokoyama T; Shimada K; Masujin K; Iwamaru Y; Imamura M; Ushiki YK; Kimura KM; Itohara S; Shinagawa M
    Arch Virol; 2007; 152(3):603-9. PubMed ID: 17106625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prion protein alpha-to-beta transition monitored by time-resolved Fourier transform infrared spectroscopy.
    Ollesch J; Künnemann E; Glockshuber R; Gerwert K
    Appl Spectrosc; 2007 Oct; 61(10):1025-31. PubMed ID: 17958950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solid-state NMR studies of the prion protein H1 fragment.
    Heller J; Kolbert AC; Larsen R; Ernst M; Bekker T; Baldwin M; Prusiner SB; Pines A; Wemmer DE
    Protein Sci; 1996 Aug; 5(8):1655-61. PubMed ID: 8844854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
    Walsh P; Yau J; Simonetti K; Sharpe S
    Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of the flexible amino-terminal domain of prion protein bound to a sulfated glycan.
    Taubner LM; Bienkiewicz EA; Copié V; Caughey B
    J Mol Biol; 2010 Jan; 395(3):475-90. PubMed ID: 19913031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High pressure NMR reveals a variety of fluctuating conformers in beta-lactoglobulin.
    Kuwata K; Li H; Yamada H; Batt CA; Goto Y; Akasaka K
    J Mol Biol; 2001 Feb; 305(5):1073-83. PubMed ID: 11162115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlated dynamics of consecutive residues reveal transient and cooperative unfolding of secondary structure in proteins.
    Lundström P; Mulder FA; Akke M
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):16984-9. PubMed ID: 16278300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-pressure NMR spectroscopy for characterizing folding intermediates and denatured states of proteins.
    Kamatari YO; Kitahara R; Yamada H; Yokoyama S; Akasaka K
    Methods; 2004 Sep; 34(1):133-43. PubMed ID: 15283922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.